Investigating inflammation in cardiometabolic health
Official title: Inflammatory Resolution in Cardiometabolic Health and Disease - an Aarhus Based Cohort
Run by University of Aarhus · NCT06390189 · Data updated 2026-11-12
This study is trying to see how inflammation affects people’s heart and metabolic health by comparing blood samples from lean, overweight, and obese volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 1 site (Aarhus) |
| Status | Recruiting |
| Started | May 7, 2024 |
| Main results expected | September 1, 2026 |
| Study ends | September 1, 2028 |
| Registry record updated | June 28, 2024 |
| Trial ID | NCT06390189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with a BMI greater than 18.5 kg/m2, categorized as either metabolically healthy or unhealthy.
✕Probably not a fit
Patients with chronic inflammation, those on immunosuppressive drugs, or individuals regularly using medications that affect inflammatory resolution may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify molecular pathways that distinguish metabolically healthy individuals from those who are unhealthy, focusing on the role of pro-resolving lipids in inflammation. Volunteers will be recruited based on their BMI, which will categorize them into lean, overweight, or obese groups. The hypothesis is that metabolically healthy individuals possess a better ability to manage inflammatory responses. The study will involve analyzing blood samples to assess inflammatory markers and lipid profiles.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic strategies for managing inflammation in cardiometabolic diseases.
How similar studies have gone: While the specific approach of this study may be novel, previous studies have shown that understanding inflammation can lead to significant advancements in treating cardiometabolic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed signed consent has been obtained from the volunteer. * The volunteer has a BMI greater than 18.5 kg/m2 * Men and women over the age of 18 are included. Exclusion Criteria: * The study staff contacting a potential participant perceives that the individual has difficulty understanding the information. * An MD determines that the individual is on too many medications to participate. * The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw. * The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication. * The individual has some form of chronic inflammation. * The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin). * The individual uses immunosuppressive drugs (e.g., methotrexate). * The individual regularly consumes fish oils (omega 3). * The individual has significant gastrointestinal problems. * The individual smokes or uses chewing tobacco. * The individual has been drinking alcohol two days before the study visit. * The individual has tattoos or body piercings on the forearms and / or the stomach that can affect the examination. * The individual does not follow instructions given in the research study.
Where it's running
-
Steno Diabetes Center Aarhus, Aarhus University Hospital
Aarhus, Denmark Recruiting
Study contacts
- Study coordinator: Emma Börgeson, PhD
- Email: emma.borgeson@biomed.au.dk
- Phone: +4593522984
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum program to prevent cardiometabolic problems after preeclampsia
This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.
-
Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.
This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.
-
Inspire HER: a heart-health and stress-support program for Black women
This project will test whether the Inspire HER lifestyle program helps Black women with higher heart disease risk improve heart health and manage stress.
-
Park-based fitness program for older adults
This study is testing whether a fitness program in local parks can help older adults aged 50 and up improve their heart health and stay active.
-
Survey to determine eligibility for cardiovascular and obesity clinical trials
This study is trying to see if people with heart issues or obesity can join new clinical trials by having them fill out a survey and undergo some health checks.
-
PREVENT: a digital tool to tailor diet and activity counseling in rural primary care
This pilot will test whether the PREVENT digital tool helps low-income rural adults with obesity get more personalized diet and physical activity advice during primary care visits.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.